WALDWICK, N.J., Jan. 17 /PRNewswire-FirstCall/ -- NEXCORE Technology, Inc, a world-class original equipment manufacturer (OEM) of medical devices, has licensed all the intellectual property rights for the development of a major advance in fluid management during endoscopic surgery. The new system provides significantly greater control over the inflow/outflow of fluids during a procedure.
The patents on the system are held by Drs. Atul and Alka Kumar. Dr. Atul Kumar, a pioneer in hysteroscopic surgery, is scientific director of the Women's Health Center in Jaipur, India. Dr. Alka Kumar is the director of the Women's Health Center.
NEXCORE is designing and developing the new system and will organize testing and FDA approval.
According to Milton Frank, President and CEO of NEXCORE, "The new system maintains a constant preset cavity pressure during operations regardless of how the flow rate of the irrigational fluid is varied allowing for optimal visualization. The system measures the intravasation rate and total fluid intravasation."
Intravasation is fluid that is absorbed into the blood vessels during a procedure, which can cause severe injury, or even death, if not properly monitored.
The new system can be used in any endoscopic surgery. It distends the
body tissue cavity by utilizing continuous flow irrigation. The new
invention increases surgical efficiency, effectiveness and safety by
maintaining a constant pressure on the mechanical distension of the cavity
and increases and maintains visibility for the surgeon.
Features unique to the new system include:
-- The fluid pressure is independent of the flow rate and the desired
cavity pressure and distention can be maintained for an indefinite
time. A clinical study published in 2004 reported that endometrial
resections were performed on 539 women using the new system without any
complications because of the system's predi
|SOURCE NEXCORE Technology, Inc|
Copyright©2008 PR Newswire.
All rights reserved